Global Differences in Disease Management Guidelines (LARS Session)

Virtual Moderator(s)

• 

  Evelyn Hsieh, M.D., Ph.D. (she/her/hers)

  Section of Rheumatology, Allergy and Immunology, Yale School of Medicine / VA Connecticut Healthcare System
  New Haven, CT, United States

  Disclosure(s): No financial relationships with ineligible companies to disclose
• 

  Eric Matteson, MD

  Mayo Clinic College of Medicine and Science
  Rochester, Minnesota, United States

  Disclosure(s): Amgen Inc: DSMB for Amgen Clinical trial (Terminated, December 20, 2024); Crystalys Therapeutics Inc: DSMB for Crystalys Clinical trial (Ongoing); Horizon Therapeutics: DSMB for Horizon Clinical trial (Terminated, December 20, 2024)

Presentations:

• 2:10 PM - 2:30 PM Central Time

  A Critical Approach to Management Guidelines in Takayasu Arteritis
  

  Virtual Speaker: Haner Direskeneli, MD – Marmara University
• 2:30 PM - 2:50 PM Central Time

  ACR Guideline Development and Geographic Adaptation
  

  Virtual Speaker: Liana Fraenkel, MD, MPH – Berkshire Medical Center
• 2:50 PM - 3:00 PM Central Time

  Introduction to Panelists
  

  Virtual Moderator: Evelyn Hsieh, M.D., Ph.D. (she/her/hers) – Section of Rheumatology, Allergy and Immunology, Yale School of Medicine / VA Connecticut Healthcare System

  Virtual Moderator: Eric Matteson, MD – Mayo Clinic College of Medicine and Science
• 3:00 PM - 3:50 PM Central Time

  PANEL Discussion
  

  Virtual Panelist: Bernhard Hellmich, MD – Medius Kliniken

  Virtual Panelist: Gilda Ferreira, PhD – Federal University of Minas Gerais

  Virtual Panelist: Bridget Hodkinson, MBBCh, PhD

  Virtual Panelist: Chi Chiu Mok, MD,FRCP – Tuen Mun Hospital

  Virtual Panelist: Tuhina Neogi, MD, PhD – Boston University School of Medicine
• 3:50 PM - 4:00 PM Central Time

  Closing Remarks
  

  Virtual Moderator: Eric Matteson, MD – Mayo Clinic College of Medicine and Science